Skip to content

Patient Controlled Administration of Liquid Acetaminophen

Patient Controlled Self-Administration of Oral Liquid Medication: Acetaminophen Trial

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06498713
Enrollment
24
Registered
2024-07-12
Start date
2024-11-19
Completion date
2025-12-31
Last updated
2025-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Pain, Postoperative

Keywords

Pain Management

Brief summary

This is a proof of concept pilot study investigating the feasibility and acceptability of patient controlled oral medication administration, using the commonly used and low risk medication in the hospital, oral acetaminophen.

Detailed description

The primary objective of this prospective pilot study is to determine the feasibility of patient-controlled administration of liquid oral acetaminophen using recruitment rate and adherence to the study protocol rate as surrogate markers. Investigators hypothesize that patients will accept the new concept of self-controlled oral administration of liquid acetaminophen, with more than 50% patient enrollment rate and less than 20% withdrawal rate from the study group to the traditional nurse-administered acetaminophen pills. The secondary objective of this study is to determine the preliminary efficacy of patient-controlled delivery of oral acetaminophen administration. If the medication is spilled or otherwise not dispensed correctly, the patients will be instructed to report this instantly to the nurse. The nurse will document and provide a replacement. All study participants have the option to call the nurse for assistance with break through pain. In addition, there is a call button to call for help with any other needs or discomfort. All other medications, such as NSAIDs or oral opioids, will be administered as prescribed. Participants will have to fill out a paper questionnaire and keep a pain diary, and nurses will have to fill out a questionnaire.

Interventions

DRUGAcetaminophen 650mg Liquid

650 mg liquid

DEVICECADD pump

Primed and programmed to delivery 650 mg liquid acetaminophen into a medication cup every 4 hours as needed.

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Patients undergoing total shoulder arthroplasty or reverse total shoulder arthroplasty at Yale New Haven Hospital at St. Raphael's Campus.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Participants * Adult patients older than 18 years old admitted to SRC for total shoulder and reverse total shoulder arthroplasty Nurses * The nurse who will administer acetaminophen to a study patient.

Exclusion criteria

Participants * Pregnant patient * Patients that cannot swallow pills or cannot take liquid (for example due to risk of aspiration) * Emergency surgery * Chronic pain * On home opioids, any other pain modulating medications including benzodiazepine, Neurontin, ketamine. * Past medical or social history of substance abuse disorder, including ethanol misuse disorder, marijuana misuse disorder * History of any psychiatric disorders including anxiety, depression, any cognitive dysfunction * Any patients who cannot provide informed consents on their own (those who would need Legally Authorized Representatives (LARs) or surrogates) * Liver dysfunction limiting amount of safe oral acetaminophen * baseline hyperbilirubinemia (ex: chronic liver disease, Gilbert's) * patients unable to take PO * Patients with neurologic, neuromuscular, or movement disorders unable to drink from a cup. Nurses * any nurse who is not involved in the direct care of a study patient, or who is not comfortable with setting up the PCA pump.

Design outcomes

Primary

MeasureTime frameDescription
Participant enrollment rateup to 12 monthsThe percentage of participants that enroll
Participant adherence to the study protocolup to 12 monthsPercentage of participants that withdraw from treatment group, i.e. switch from patient controlled liquid group to the nurse-administered pill control group
Nurse QuestionnaireStudy day 0, 1, 2 and 3Nurse ranking of patient controlled liquid oral acetaminophen vs. nurse-administered pill acetaminophen. (Mean score, Total Scale of 0-10: 0: much worse; 5:same; 10: much better)

Secondary

MeasureTime frameDescription
Mean daily acetaminophen consumption12 monthsMean daily acetaminophen consumption in milligrams collected using the electronic medical record
Mean Pain score12 monthsParticipants will be asked via Pain Diary to rate their pain using numeric pain scores from 0 to 10, 0 as no pain, 10 is the worst possible.
Mean time to medication delivery12 monthsMedication delivery: Mean time in minutes from the time when pain medication requested by the participant to the time pain medication is delivered

Countries

United States

Contacts

Primary ContactJinlei Li, MD, PhD
jinlei.li@yale.edu475-434-4038

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026